TP53 c.98C>A ;(p.S33Y)

Variant ID: 17-7579589-G-T

NM_000546.5(TP53):c.98C>A;(p.S33Y)

This variant was identified in 48 publications

View GRCh38 version.




Publications:


Heat Shock Transcription Factor 2 Is Significantly Involved in Neurodegenerative Diseases, Inflammatory Bowel Disease, Cancer, Male Infertility, and Fetal Alcohol Spectrum Disorder: The Novel Mechanisms of Several Severe Diseases.

International Journal Of Molecular Sciences
Tokunaga, Yasuko Y; Otsuyama, Ken-Ichiro KI; Kakuta, Shigeru S; Hayashida, Naoki N
Publication Date: 2022-11-09

Variant appearance in text: p53: Ser33Tyr
PubMed Link: 36430241
Variant Present in the following documents:
  • Main text
  • ijms-23-13763.pdf
View BVdb publication page



Proteogenomic characterization of 2002 human cancers reveals pan-cancer molecular subtypes and associated pathways.

Nature Communications
Zhang, Yiqun Y; Chen, Fengju F; Chandrashekar, Darshan S DS; Varambally, Sooryanarayana S; Creighton, Chad J CJ
Publication Date: 2022-05-13

Variant appearance in text: p53: S33Y
PubMed Link: 35562349
Variant Present in the following documents:
  • 41467_2022_30342_MOESM4_ESM.xlsx, sheet 1
View BVdb publication page



Targeting Myc-driven stress vulnerability in mutant KRAS colorectal cancer.

Molecular Biomedicine
Ruan, Hang H; Leibowitz, Brian J BJ; Peng, Yingpeng Y; Shen, Lin L; Chen, Lujia L; Kuang, Charlie C; Schoen, Robert E RE; Lu, Xinghua X; Zhang, Lin L; Yu, Jian J
Publication Date: 2022-03-21

Variant appearance in text: TP53: S33Y
PubMed Link: 35307764
Variant Present in the following documents:
  • 43556_2022_70_MOESM1_ESM.pdf
View BVdb publication page



Immune Dysfunction, Cytokine Disruption, and Stromal Changes in Myelodysplastic Syndrome: A Review.

Cells
Lynch, Olivia F OF; Calvi, Laura M LM
Publication Date: 2022-02-08

Variant appearance in text: TP53: S33Y
PubMed Link: 35159389
Variant Present in the following documents:
  • Main text
  • cells-11-00580.pdf
View BVdb publication page



Immune Dysfunction, Cytokine Disruption, and Stromal Changes in Myelodysplastic Syndrome: A Review.

Cells
Lynch, Olivia F OF; Calvi, Laura M LM
Publication Date: 2022-02-08

Variant appearance in text: TP53: S33Y
PubMed Link: 35159389
Variant Present in the following documents:
  • Main text
  • cells-11-00580.pdf
View BVdb publication page



A computational and structural analysis of germline and somatic variants affecting the DDR mechanism, and their impact on human diseases.

Scientific Reports
Magraner-Pardo, Lorena L; Laskowski, Roman A RA; Pons, Tirso T; Thornton, Janet M JM
Publication Date: 2021-07-12

Variant appearance in text: TP53: 98C>A; S33Y
PubMed Link: 34253785
Variant Present in the following documents:
  • 41598_2021_93715_MOESM2_ESM.xlsx, sheet 8
View BVdb publication page



Genomic profiling reveals heterogeneous populations of ductal carcinoma in situ of the breast.

Communications Biology
Nagasawa, Satoi S; Kuze, Yuta Y; Maeda, Ichiro I; Kojima, Yasuyuki Y; Motoyoshi, Ai A; Onishi, Tatsuya T; Iwatani, Tsuguo T; Yokoe, Takamichi T; Koike, Junki J; Chosokabe, Motohiro M; Kubota, Manabu M; Seino, Hibiki H; Suzuki, Ayako A; Seki, Masahide M; Tsuchihara, Katsuya K; Inoue, Eisuke E; Tsugawa, Koichiro K; Ohta, Tomohiko T; Suzuki, Yutaka Y
Publication Date: 2021-04-01

Variant appearance in text: TP53: S33Y
PubMed Link: 33795819
Variant Present in the following documents:
  • 42003_2021_1959_MOESM10_ESM.xlsx, sheet 1
View BVdb publication page



Targeted Next-Generation Sequencing of Plasma Cell-Free DNA in Korean Patients with Hepatocellular Carcinoma.

Annals Of Laboratory Medicine
Chae, Hyojin H; Sung, Pil Soo PS; Choi, Hayoung H; Kwon, Ahlm A; Kang, Dain D; Kim, Yonggoo Y; Kim, Myungshin M; Yoon, Seung Kew SK
Publication Date: 2021-03-01

Variant appearance in text: TP53: 98C>A
PubMed Link: 33063681
Variant Present in the following documents:
  • ALM-41-198.pdf
View BVdb publication page



CD147 promotes collective invasion through cathepsin B in hepatocellular carcinoma.

Journal Of Experimental & Clinical Cancer Research : Cr
Wang, Shi-Jie SJ; Chao, Dong D; Wei, Wei W; Nan, Gang G; Li, Jia-Yue JY; Liu, Fen-Ling FL; Li, Ling L; Jiang, Jian-Li JL; Cui, Hong-Yong HY; Chen, Zhi-Nan ZN
Publication Date: 2020-07-29

Variant appearance in text: p53: S33Y
PubMed Link: 32727598
Variant Present in the following documents:
  • Main text
  • 13046_2020_Article_1647.pdf
View BVdb publication page



BRAF mutant colorectal cancer: ErbB2 expression levels as predictive factor for the response to combined BRAF/ErbB inhibitors.

Bmc Cancer
Miele, Evelina E; Abballe, Luana L; Spinelli, Gian Paolo GP; Besharat, Zein Mersini ZM; Catanzaro, Giuseppina G; Chiacchiarini, Martina M; Vacca, Alessandra A; Po, Agnese A; Capalbo, Carlo C; Ferretti, Elisabetta E
Publication Date: 2020-02-17

Variant appearance in text: TP53: S33Y
PubMed Link: 32066410
Variant Present in the following documents:
  • Main text
View BVdb publication page



Tumor genetic heterogeneity analysis of chronic sun-damaged melanoma.

Pigment Cell & Melanoma Research
Sanna, Adriana A; Harbst, Katja K; Johansson, Iva I; Christensen, Gustav G; Lauss, Martin M; Mitra, Shamik S; Rosengren, Frida F; Häkkinen, Jari J; Vallon-Christersson, Johan J; Olsson, Håkan H; Ingvar, Åsa Å; Isaksson, Karolin K; Ingvar, Christian C; Nielsen, Kari K; Jönsson, Göran G
Publication Date: 2020-05

Variant appearance in text: TP53: Ser33Tyr
PubMed Link: 31811783
Variant Present in the following documents:
  • PCMR-33-480.pdf
View BVdb publication page



APLN promotes hepatocellular carcinoma through activating PI3K/Akt pathway and is a druggable target.

Theranostics
Chen, Huarong H; Wong, Chi-Chun CC; Liu, Dabin D; Go, Minnie Y Y MYY; Wu, Bin B; Peng, Sui S; Kuang, Ming M; Wong, Nathalie N; Yu, Jun J
Publication Date: 2019

Variant appearance in text: p53: S33Y
PubMed Link: 31410213
Variant Present in the following documents:
  • Main text
  • thnov09p5246.pdf
View BVdb publication page



C-terminal α Domain of p63 Binds to p300 to Coactivate β-Catenin.

Neoplasia (New York, N.Y.)
Katoh, Iyoko I; Maehata, Yojiro Y; Moriishi, Kohji K; Hata, Ryu-Ichiro RI; Kurata, Shun-Ichi SI
Publication Date: 2019-05

Variant appearance in text: p53: S33Y
PubMed Link: 30986748
Variant Present in the following documents:
  • Main text
  • main.pdf
View BVdb publication page



From uncertainty to pathogenicity: clinical and functional interrogation of a rare TP53 in-frame deletion.

Cold Spring Harbor Molecular Case Studies
Quinn, Emily A EA; Maciaszek, Jamie L JL; Pinto, Emilia M EM; Phillips, Aaron H AH; Berdy, David D; Khandwala, Mohammad M; Upadhyaya, Santhosh A SA; Zambetti, Gerard P GP; Kriwacki, Richard W RW; Ellison, David W DW; Nichols, Kim E KE; Kesserwan, Chimene C
Publication Date: 2019-08

Variant appearance in text: TP53: 98C>A; Ser33Tyr
PubMed Link: 30886117
Variant Present in the following documents:
  • supp_mcs.a003921_Supplemental_Table_1a.xlsx, sheet 1
View BVdb publication page



Mutation Hotspots in the β-Catenin Gene: Lessons from the Human Cancer Genome Databases.

Molecules And Cells
Kim, Sewoon S; Jeong, Sunjoo S
Publication Date: 2019-01-31

Variant appearance in text: TP53: S33Y
PubMed Link: 30699286
Variant Present in the following documents:
  • Main text
View BVdb publication page



Pin1 Modulation in Physiological Status and Neurodegeneration. Any Contribution to the Pathogenesis of Type 3 Diabetes?

International Journal Of Molecular Sciences
Bianchi, Marzia M; Manco, Melania M
Publication Date: 2018-08-08

Variant appearance in text: p53: S33Y
PubMed Link: 30096758
Variant Present in the following documents:
  • Main text
  • ijms-19-02319.pdf
View BVdb publication page



The anti-cancer activity of an andrographolide analogue functions through a GSK-3β-independent Wnt/β-catenin signaling pathway in colorectal cancer cells.

Scientific Reports
Reabroi, Somrudee S; Saeeng, Rungnapha R; Boonmuen, Nittaya N; Kasemsuk, Teerapich T; Saengsawang, Witchuda W; Suksen, Kanoknetr K; Zhu, Weiming W; Piyachaturawat, Pawinee P; Chairoungdua, Arthit A
Publication Date: 2018-05-21

Variant appearance in text: p53: S33Y
PubMed Link: 29784906
Variant Present in the following documents:
  • Main text
  • 41598_2018_Article_26278.pdf
View BVdb publication page



Development of a highly sensitive liquid biopsy platform to detect clinically-relevant cancer mutations at low allele fractions in cell-free DNA.

Plos One
Gale, Davina D; Lawson, Andrew R J ARJ; Howarth, Karen K; Madi, Mikidache M; Durham, Bradley B; Smalley, Sarah S; Calaway, John J; Blais, Shannon S; Jones, Greg G; Clark, James J; Dimitrov, Peter P; Pugh, Michelle M; Woodhouse, Samuel S; Epstein, Michael M; Fernandez-Gonzalez, Ana A; Whale, Alexandra S AS; Huggett, Jim F JF; Foy, Carole A CA; Jones, Gerwyn M GM; Raveh-Amit, Hadas H; Schmitt, Karin K; Devonshire, Alison A; Green, Emma E; Forshew, Tim T; Plagnol, Vincent V; Rosenfeld, Nitzan N
Publication Date: 2018

Variant appearance in text: TP53: S33Y
PubMed Link: 29547634
Variant Present in the following documents:
  • pone.0194630.s014.xlsx, sheet 1
View BVdb publication page



Dimethyl fumarate is highly cytotoxic in KRAS mutated cancer cells but spares non-tumorigenic cells.

Oncotarget
Bennett Saidu, Nathaniel Edward NE; Bretagne, Marie M; Mansuet, Audrey Lupo AL; Just, Pierre-Alexandre PA; Leroy, Karen K; Cerles, Olivier O; Chouzenoux, Sandrine S; Nicco, Carole C; Damotte, Diane D; Alifano, Marco M; Borghese, Bruno B; Goldwasser, François F; Batteux, Frédéric F; Alexandre, Jérôme J
Publication Date: 2018-02-06

Variant appearance in text: TP53: Ser33Tyr
PubMed Link: 29507676
Variant Present in the following documents:
  • Main text
View BVdb publication page



USP7 Is a Tumor-Specific WNT Activator for APC-Mutated Colorectal Cancer by Mediating β-Catenin Deubiquitination.

Cell Reports
Novellasdemunt, Laura L; Foglizzo, Valentina V; Cuadrado, Laura L; Antas, Pedro P; Kucharska, Anna A; Encheva, Vesela V; Snijders, Ambrosius P AP; Li, Vivian S W VSW
Publication Date: 2017-10-17

Variant appearance in text: p53: S33Y
PubMed Link: 29045831
Variant Present in the following documents:
  • Main text
View BVdb publication page



Using a novel computational drug-repositioning approach (DrugPredict) to rapidly identify potent drug candidates for cancer treatment.

Oncogene
Nagaraj, A B AB; Wang, Q Q QQ; Joseph, P P; Zheng, C C; Chen, Y Y; Kovalenko, O O; Singh, S S; Armstrong, A A; Resnick, K K; Zanotti, K K; Waggoner, S S; Xu, R R; DiFeo, A A
Publication Date: 2018-01-18

Variant appearance in text: TP53: S33Y
PubMed Link: 28967908
Variant Present in the following documents:
  • Main text
  • onc2017328a.pdf
View BVdb publication page



Nuclear α-catenin mediates the DNA damage response via β-catenin and nuclear actin.

Journal Of Cell Science
Serebryannyy, Leonid A LA; Yemelyanov, Alex A; Gottardi, Cara J CJ; de Lanerolle, Primal P
Publication Date: 2017-05-15

Variant appearance in text: p53: S33Y
PubMed Link: 28348105
Variant Present in the following documents:
  • Main text
View BVdb publication page



RANKL coordinates multiple osteoclastogenic pathways by regulating expression of ubiquitin ligase RNF146.

The Journal Of Clinical Investigation
Matsumoto, Yoshinori Y; Larose, Jose J; Kent, Oliver A OA; Lim, Melissa M; Changoor, Adele A; Zhang, Lucia L; Storozhuk, Yaryna Y; Mao, Xiaohong X; Grynpas, Marc D MD; Cong, Feng F; Rottapel, Robert R
Publication Date: 2017-04-03

Variant appearance in text: p53: S33Y
PubMed Link: 28287403
Variant Present in the following documents:
  • Main text
View BVdb publication page



Narrowing the focus: a toolkit to systematically connect oncogenic signaling pathways with cancer phenotypes.

Genes & Cancer
Singleton, Katherine R KR; Wood, Kris C KC
Publication Date: 2016-07

Variant appearance in text: p53: S33Y
PubMed Link: 27738492
Variant Present in the following documents:
  • Main text
View BVdb publication page



iFish: predicting the pathogenicity of human nonsynonymous variants using gene-specific/family-specific attributes and classifiers.

Scientific Reports
Wang, Meng M; Wei, Liping L
Publication Date: 2016-08-16

Variant appearance in text: TP53: S33Y
PubMed Link: 27527004
Variant Present in the following documents:
  • srep31321-s5.xls, sheet 1
View BVdb publication page



β-Catenin C-terminal signals suppress p53 and are essential for artery formation.

Nature Communications
Riascos-Bernal, Dario F DF; Chinnasamy, Prameladevi P; Cao, Longyue Lily LL; Dunaway, Charlene M CM; Valenta, Tomas T; Basler, Konrad K; Sibinga, Nicholas E S NE
Publication Date: 2016-08-08

Variant appearance in text: p53: S33Y
PubMed Link: 27499244
Variant Present in the following documents:
  • Main text
  • ncomms12389.pdf
View BVdb publication page



Inhibition of Wnt Signaling by Silymarin in Human Colorectal Cancer Cells.

Biomolecules & Therapeutics
Eo, Hyun Ji HJ; Park, Gwang Hun GH; Jeong, Jin Boo JB
Publication Date: 2016-07-01

Variant appearance in text: p53: S33Y
PubMed Link: 27068260
Variant Present in the following documents:
  • bt-24-380.pdf
View BVdb publication page



Repression of Wnt/β-catenin response elements by p63 (TP63).

Cell Cycle (Georgetown, Tex.)
Katoh, Iyoko I; Fukunishi, Nahoko N; Fujimuro, Masahiro M; Kasai, Hirotake H; Moriishi, Kohji K; Hata, Ryu-Ichiro R; Kurata, Shun-Ichi S
Publication Date: 2016

Variant appearance in text: p53: S33Y
PubMed Link: 26890356
Variant Present in the following documents:
  • Main text
  • kccy-15-05-1148837-s001.pdf
View BVdb publication page



Inhibition of glycogen synthase kinase-3 beta induces apoptosis and mitotic catastrophe by disrupting centrosome regulation in cancer cells.

Scientific Reports
Yoshino, Yuki Y; Ishioka, Chikashi C
Publication Date: 2015-08-21

Variant appearance in text: p53: S33Y
PubMed Link: 26292722
Variant Present in the following documents:
  • Main text
View BVdb publication page



RAS/MAPK Activation Drives Resistance to Smo Inhibition, Metastasis, and Tumor Evolution in Shh Pathway-Dependent Tumors.

Cancer Research
Zhao, Xuesong X; Ponomaryov, Tatyana T; Ornell, Kimberly J KJ; Zhou, Pengcheng P; Dabral, Sukriti K SK; Pak, Ekaterina E; Li, Wei W; Atwood, Scott X SX; Whitson, Ramon J RJ; Chang, Anne Lynn S AL; Li, Jiang J; Oro, Anthony E AE; Chan, Jennifer A JA; Kelleher, Joseph F JF; Segal, Rosalind A RA
Publication Date: 2015-09-01

Variant appearance in text: p53: S33Y
PubMed Link: 26130651
Variant Present in the following documents:
  • Main text
View BVdb publication page



TCF4 Is a Molecular Target of Resveratrol in the Prevention of Colorectal Cancer.

International Journal Of Molecular Sciences
Jeong, Jin Boo JB; Lee, Jihye J; Lee, Seong-Ho SH
Publication Date: 2015-05-07

Variant appearance in text: p53: S33Y
PubMed Link: 25961950
Variant Present in the following documents:
  • Main text
  • ijms-16-10411.pdf
View BVdb publication page



Telomere protection and TRF2 expression are enhanced by the canonical Wnt signalling pathway.

Embo Reports
Diala, Irmina I; Wagner, Nicole N; Magdinier, Frédérique F; Shkreli, Marina M; Sirakov, Maria M; Bauwens, Serge S; Schluth-Bolard, Caroline C; Simonet, Thomas T; Renault, Valérie M VM; Ye, Jing J; Djerbi, Abdelnnadir A; Pineau, Pascal P; Choi, Jinkuk J; Artandi, Steven S; Dejean, Anne A; Plateroti, Michelina M; Gilson, Eric E
Publication Date: 2013-04

Variant appearance in text: p53: S33Y
PubMed Link: 23429341
Variant Present in the following documents:
  • Main text
View BVdb publication page



An array CGH based genomic instability index (G2I) is predictive of clinical outcome in breast cancer and reveals a subset of tumors without lymph node involvement but with poor prognosis.

Bmc Medical Genomics
Bonnet, Françoise F; Guedj, Mickael M; Jones, Natalie N; Sfar, Sana S; Brouste, Véronique V; Elarouci, Nabila N; Banneau, Guillaume G; Orsetti, Béatrice B; Primois, Charlotte C; de Lara, Christine Tunon CT; Debled, Marc M; de Mascarel, Isabelle I; Theillet, Charles C; Sévenet, Nicolas N; de Reynies, Aurélien A; MacGrogan, Gaëtan G; Longy, Michel M
Publication Date: 2012-11-27

Variant appearance in text: TP53: 98C>A
PubMed Link: 23186559
Variant Present in the following documents:
  • 1755-8794-5-54-S1.pdf
View BVdb publication page



Activation of Wnt/β-catenin protein signaling induces mitochondria-mediated apoptosis in hematopoietic progenitor cells.

The Journal Of Biological Chemistry
Ming, Ming M; Wang, Sheng S; Wu, Wenshu W; Senyuk, Vitalyi V; Le Beau, Michelle M MM; Nucifora, Giuseppina G; Qian, Zhijian Z
Publication Date: 2012-06-29

Variant appearance in text: p53: S33Y
PubMed Link: 22589536
Variant Present in the following documents:
  • Main text
View BVdb publication page



Inhibition of β-catenin signaling by nongenomic action of orphan nuclear receptor Nur77.

Oncogene
Sun, Z Z; Cao, X X; Jiang, M-M MM; Qiu, Y Y; Zhou, H H; Chen, L L; Qin, B B; Wu, H H; Jiang, F F; Chen, J J; Liu, J J; Dai, Y Y; Chen, H-F HF; Hu, Q-Y QY; Wu, Z Z; Zeng, J-Z JZ; Yao, X-S XS; Zhang, X-K XK
Publication Date: 2012-05-24

Variant appearance in text: p53: S33Y
PubMed Link: 21986938
Variant Present in the following documents:
  • Main text
View BVdb publication page



Silencing of the Wnt transcription factor TCF4 sensitizes colorectal cancer cells to (chemo-) radiotherapy.

Carcinogenesis
Kendziorra, Emil E; Ahlborn, Kerstin K; Spitzner, Melanie M; Rave-Fränk, Margret M; Emons, Georg G; Gaedcke, Jochen J; Kramer, Frank F; Wolff, Hendrik A HA; Becker, Heinz H; Beissbarth, Tim T; Ebner, Reinhard R; Ghadimi, B Michael BM; Pukrop, Tobias T; Ried, Thomas T; Grade, Marian M
Publication Date: 2011-12

Variant appearance in text: p53: S33Y
PubMed Link: 21983179
Variant Present in the following documents:
  • Main text
View BVdb publication page



Mutant KRAS promotes hyperplasia and alters differentiation in the colon epithelium but does not expand the presumptive stem cell pool.

Gastroenterology
Feng, Ying Y; Bommer, Guido T GT; Zhao, Jenny J; Green, Maranne M; Sands, Evan E; Zhai, Yali Y; Brown, Kelly K; Burberry, Aaron A; Cho, Kathleen R KR; Fearon, Eric R ER
Publication Date: 2011-09

Variant appearance in text: p53: S33Y
PubMed Link: 21699772
Variant Present in the following documents:
  • Main text
View BVdb publication page



Exosome release of β-catenin: a novel mechanism that antagonizes Wnt signaling.

The Journal Of Cell Biology
Chairoungdua, Arthit A; Smith, Danielle L DL; Pochard, Pierre P; Hull, Michael M; Caplan, Michael J MJ
Publication Date: 2010-09-20

Variant appearance in text: p53: S33Y
PubMed Link: 20837771
Variant Present in the following documents:
  • JCB_201002049.pdf
View BVdb publication page



KRAS/BRAF mutation status and ERK1/2 activation as biomarkers for MEK1/2 inhibitor therapy in colorectal cancer.

Molecular Cancer Therapeutics
Yeh, Jen Jen JJ; Routh, Elizabeth D ED; Rubinas, Tara T; Peacock, Janie J; Martin, Timothy D TD; Shen, Xiang Jun XJ; Sandler, Robert S RS; Kim, Hong Jin HJ; Keku, Temitope O TO; Der, Channing J CJ
Publication Date: 2009-04

Variant appearance in text: TP53: S33Y
PubMed Link: 19372556
Variant Present in the following documents:
  • Main text
View BVdb publication page



Tumor hypoxia blocks Wnt processing and secretion through the induction of endoplasmic reticulum stress.

Molecular And Cellular Biology
Verras, Meletios M; Papandreou, Ioanna I; Lim, Ai Lin AL; Denko, Nicholas C NC
Publication Date: 2008-12

Variant appearance in text: p53: S33Y
PubMed Link: 18824543
Variant Present in the following documents:
  • Main text
View BVdb publication page



E2F1 represses beta-catenin transcription and is antagonized by both pRB and CDK8.

Nature
Morris, Erick J EJ; Ji, Jun-Yuan JY; Yang, Fajun F; Di Stefano, Luisa L; Herr, Anabel A; Moon, Nam-Sung NS; Kwon, Eun-Jeong EJ; Haigis, Kevin M KM; Näär, Anders M AM; Dyson, Nicholas J NJ
Publication Date: 2008-09-25

Variant appearance in text: p53: S33Y
PubMed Link: 18794899
Variant Present in the following documents:
  • Main text
View BVdb publication page



Regulation of vascular endothelial growth factor expression by homeodomain-interacting protein kinase-2.

Journal Of Experimental & Clinical Cancer Research : Cr
Puca, Rosa R; Nardinocchi, Lavinia L; D'Orazi, Gabriella G
Publication Date: 2008-07-21

Variant appearance in text: p53: S33Y
PubMed Link: 18644116
Variant Present in the following documents:
  • Main text
View BVdb publication page



Yale University School of Medicine Thesis Abstracts - 2004.

The Yale Journal Of Biology And Medicine
Publication Date: 2004-01

Variant appearance in text: p53: S33Y
PubMed Link: 18170931
Variant Present in the following documents:
  • 18170931.pdf
View BVdb publication page



Analysis of endogenous LRP6 function reveals a novel feedback mechanism by which Wnt negatively regulates its receptor.

Molecular And Cellular Biology
Khan, Zahid Z; Vijayakumar, Sapna S; de la Torre, Teresa Villanueva TV; Rotolo, Sabrina S; Bafico, Anna A
Publication Date: 2007-10

Variant appearance in text: p53: S33Y
PubMed Link: 17698587
Variant Present in the following documents:
  • Main text
View BVdb publication page



Engrailed-1 negatively regulates beta-catenin transcriptional activity by destabilizing beta-catenin via a glycogen synthase kinase-3beta-independent pathway.

Molecular Biology Of The Cell
Bachar-Dahan, Liora L; Goltzmann, Janna J; Yaniv, Abraham A; Gazit, Arnona A
Publication Date: 2006-06

Variant appearance in text: p53: S33Y
PubMed Link: 16571670
Variant Present in the following documents:
  • Main text
View BVdb publication page



Beta-catenin regulation during the cell cycle: implications in G2/M and apoptosis.

Molecular Biology Of The Cell
Olmeda, David D; Castel, Susanna S; Vilaró, Senén S; Cano, Amparo A
Publication Date: 2003-07

Variant appearance in text: p53: S33Y
PubMed Link: 12857869
Variant Present in the following documents:
  • Main text
View BVdb publication page



The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus manipulates the activity of glycogen synthase kinase-3beta.

Journal Of Virology
Fujimuro, Masahiro M; Hayward, S Diane SD
Publication Date: 2003-07

Variant appearance in text: p53: S33Y
PubMed Link: 12829841
Variant Present in the following documents:
  • Main text
View BVdb publication page



Down-regulation of beta-catenin by activated p53.

Molecular And Cellular Biology
Sadot, E E; Geiger, B B; Oren, M M; Ben-Ze'ev, A A
Publication Date: 2001-10

Variant appearance in text: p53: S33Y
PubMed Link: 11564862
Variant Present in the following documents:
  • Main text
View BVdb publication page



Deregulated beta-catenin induces a p53- and ARF-dependent growth arrest and cooperates with Ras in transformation.

The Embo Journal
Damalas, A A; Kahan, S S; Shtutman, M M; Ben-Ze'ev, A A; Oren, M M
Publication Date: 2001-09-03

Variant appearance in text: p53: S33Y
PubMed Link: 11532955
Variant Present in the following documents:
  • Main text
View BVdb publication page